510(k) Report

510(k) · Cleared

Cleared

Laserscope Guided Delivery Device (GDD) Cystourethroscope & Accessories

K061646510(k) TraditionalCleared Jun 27, 200615-day reviewClass II21 CFR 876.1500

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Laserscope · FBO Cystourethroscope

Cleared on Jun 27, 2006 after a 15-day review. The FDA summary names its predicate without a number.

Decided
Jun 27, 2006
Review
15 days
Class
Class II
Product code
FBO
Recalls
None
Predicates
0

The FDA summary names its predicate without a number.

FIG. 1 — Lineage of K061646Source: FDA 510(k) database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FBO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FBO device

  1. #1 K244001 KARL STORZ Cysto-Urethro-Fiberscope…score 9.3 · 1 generation · no Class I recall
  2. #2 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—Stryker Urology and Gynecology Hardware System
Named without a submission number
—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All FBO devices

FBO Cystourethroscope: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · FBO

1in 2025

2007: 12008: 22014: 12024: 12025: 1
2007high 2 (2008) · low 0 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FBO

Too few FBO 510(k)s in any year since 2007 to give a median.

Recalls per year · FBO

1in 2023

2022: 52023: 1
2007high 5 (2022) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · FBO

26in 2025

2008: 32009: 22010: 32011: 32012: 72013: 52014: 102015: 102016: 92017: 112018: 112019: 152020: 202021: 182022: 332023: 292024: 302025: 26
2007high 33 (2022) · low 0 (2007)2025

MAUDE reports naming product code FBO, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20082—03
20090—02
20100—03
20110—03
20120—07
20130—05
20141—010
20150—010
20160—09
20170—011
20180—011
20190—015
20200—020
20210—018
20220—533
20230—129
20241—030
20251—026
20260—0—

What is it indicated for?

The Laserscope GDD Cystourethroscope Hardware System is intended to provide the user with the means for endoscopic diagnostic and therapeutic surgical procedures. Examples of use of the product include the visualization and manipulation of anatomy, ablation, biopsy, incision, and resection of tissue, and/or as the surgeon deems appropriate. The system is intended for use in general urological surgery through minimally invasive approach by utilizing…

Read the full statement (107 words)

The Laserscope GDD Cystourethroscope Hardware System is intended to provide the user with the means for endoscopic diagnostic and therapeutic surgical procedures. Examples of use of the product include the visualization and manipulation of anatomy, ablation, biopsy, incision, and resection of tissue, and/or as the surgeon deems appropriate. The system is intended for use in general urological surgery through minimally invasive approach by utilizing natural orifices to access the surgical site. The system's use is intended for, but not limited to the following types of procedures:

Dilation of the urethra and cold slitting strictures

Trans-urethral incision, vaporization, and resection of the prostrate

Trans-urethral removal of bladder tumors

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K061646: Laserscope Guided Delivery Device (GDD) Cystourethroscope & Accessories.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K061646

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Page last updated Nov 3, 2026